Details for New Drug Application (NDA): 062723
✉ Email this page to a colleague
The generic ingredient in CEPHAPIRIN SODIUM is cephapirin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephapirin sodium profile page.
Summary for 062723
Tradename: | CEPHAPIRIN SODIUM |
Applicant: | Abraxis Pharm |
Ingredient: | cephapirin sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 062723
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Nov 17, 1986 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Nov 17, 1986 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
Approval Date: | Nov 17, 1986 | TE: | RLD: | No |
Complete Access Available with Subscription